Fentanyl

"Fentanyl" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Descriptor ID	D005283
MeSH Number(s)	D03.383.621.265
Concept/Terms	Fentanyl Fentanyl Phentanyl Fentanest Fentanest Fentanyl Citrate Fentanyl Citrate R-4263 R-4263 R 4263 R4263 Sublimaze Sublimaze Transmucosal Oral Fentanyl Citrate Transmucosal Oral Fentanyl Citrate Duragesic Duragesic Durogesic Fentora Fentora

Below are MeSH descriptors whose meaning is more general than "Fentanyl".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Piperidines [D03.383.621]
Fentanyl [D03.383.621.265]

Below are MeSH descriptors whose meaning is related to "Fentanyl".

Below are MeSH descriptors whose meaning is more specific than "Fentanyl".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fentanyl" by people in this website by year, and whether "Fentanyl" was a major or minor topic of these publications.

Bar chart showing 45 publications over 21 distinct years, with a maximum of 6 publications in 2022 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1998	0	1	1
1999	1	1	2
2000	2	0	2
2001	1	1	2
2002	1	1	2
2003	1	0	1
2004	0	1	1
2007	0	1	1
2010	2	0	2
2011	1	1	2
2014	2	1	3
2015	1	0	1
2016	1	0	1
2017	2	1	3
2020	0	1	1
2021	1	0	1
2022	1	5	6
2023	1	2	3
2024	5	1	6
2025	1	2	3

Below are the most recent publications written about "Fentanyl" by people in Profiles.

Rettger B, Chapman BP, Krotulski A, Gigliotti R, Polackal J, Olabisi D, Nguyen J, Cotoni B, Hunter M, Merchant RC, Walton S, Logan BK, Martinez PM, Weisberg SN, Broach JP, Babu KM. Identifying the Local Emergence of Medetomidine Through Prehospital Collaborations. Prehosp Emerg Care. 2025; 29(4):338-342.

View in: PubMed
Williams BE, Martin SA, Hoffman KA, Andrus MD, Dellabough-Gormley E, Buchheit BM. "It's within your own power": shared decision-making to support transitions to buprenorphine. Addict Sci Clin Pract. 2025 Mar 07; 20(1):22.

View in: PubMed
Williams BR, Gamble MC, Singh N, Bryant CD, Logan BA, Logan RW. Sleep and circadian rhythm activity alterations during adolescence in a mouse model of neonatal fentanyl withdrawal syndrome. Neuroscience. 2025 Mar 17; 569:85-91.

View in: PubMed
Beasley SM, Zaihra Rizvi T, Grgurich PE. A Comparative Study of Fentanyl Versus Hydromorphone in Mechanically Ventilated Intensive Care Unit Patients. Ann Pharmacother. 2025 Jul; 59(7):593-603.

View in: PubMed
Uljon S, Tolan NV, Mahowald GK, Khaliq T, Urwiller ED, Fernandes MD, Basu SS, Kang P, Erickson TB, Hayes BD, Chai PR, Melanson SEF. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl. J Appl Lab Med. 2024 Sep 03; 9(5):895-904.

View in: PubMed
Soares WE, Schoenfeld E, Friedmann PD. Precipitated Withdrawal in the Era of Street Fentanyl-The Important Thing Is to Not Stop Questioning. JAMA Netw Open. 2024 09 03; 7(9):e2435857.

View in: PubMed
Grande LA, Hutch T, Jack K, Mironov W, Iwuoha J, Muy-Rivera M, Grillo J, Martin SA, Herring A. Ketamine-assisted buprenorphine initiation: a pilot case series. Addict Sci Clin Pract. 2024 Aug 29; 19(1):60.

View in: PubMed
Myers LC, Bosch NA, Soltesz L, Daly KA, Campbell CI, Schwager E, Salvati E, Stevens JP, Wunsch H, Rucci JM, Jafarzadeh SR, Liu VX, Walkey AJ. Opioid Administration Practice Patterns in Patients With Acute Respiratory Failure Who Undergo Invasive Mechanical Ventilation. Crit Care Explor. 2024 Jul 01; 6(7):e1123.

View in: PubMed
Gamble MC, Miracle S, Williams BR, Logan RW. Endocannabinoid agonist 2-arachidonoylglycerol differentially alters diurnal activity and sleep during fentanyl withdrawal in male and female mice. Pharmacol Biochem Behav. 2024 07; 240:173791.

View in: PubMed
Barnett BS, Chai PR, Suzuki J. Scaling Up Point-of-Care Fentanyl Testing - A Step Forward. N Engl J Med. 2023 11 02; 389(18):1643-1645.

View in: PubMed

People

Explore

Similar Concepts

Top Journals